The QualityStocks Daily Wednesday, October 6th, 2021

Today's Top 3 Investment Newsletters

MarketClub Analysis(GROM) $4.9800 +49.55%

NetworkNewsWire(SGTM) $2.6600 +33.67%

QualityStocks(FAMI) $0.3938 +21.36%

The QualityStocks Daily Stock List

Icoa Inc. (ICOA)

OTC Picks, OTCPicks, PennyTrader Publisher, FeedBlitz, Stock Rich, Stock Analyzer, Pumps and Dumps, HotOTC, Epic Stock Picks, CoolPennyStocks, BullRally and Bloomfield Investment Club reported earlier on Icoa Inc. (ICOA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Icoa Inc. (OTC: ICOA) is focused on the provision of wired broadband internet and neutral-host wireless services.

The firm has its headquarters in Warwick, Rhode Island and was incorporated in 1983. Prior to its name change in March 1989, the firm was known as Quintonix Inc. The firm serves consumers across the United States.

The company operates and installs Wi-Fi hotspots in public areas like retail businesses, apartment buildings and airports across the U.S. Its airport clients include facilities in Idaho, Boise, California and Fresno while its retail users include restaurants like Panda Express and Panera Bread.

The enterprise’s LinkSport targets outdoor recreation areas and RV parks while its iDockUSA subsidiary is focused on marinas. It provides network advisory services; procurement, configuration and installation network equipment services; and content management flexibility, business intelligence, billing and administration services. It also provides office solutions for wireless service providers and hotspot operators. This is in addition to designing, installing, operating, maintaining and managing hot zone infrastructure, common-use 802.11x standard WLAN Wi-Fi hotspot and neutral facilities in the municipal/hot zone, hospitality, marinas, travel plazas, universities, quick-service restaurants and airport locations. Furthermore, its offers software known as Tollbooth, which can be used to managed wireless network user authentication, customer service and billing functions.

The company plans to acquire iBG Finance, which is the only insured-DeFi project globally. This move will open new markets and afford the company new opportunities, which may boost its growth and bring more investors into the company.

Icoa Inc. (ICOA), closed Wednesday’s trading session at $0.0183, off by 7.1066%, on 50,320,521 volume.The average volume for the last 3 months is 19.829M and the stock's 52-week low/high is $0.000001/$0.0279.

All American Pet Company (AAPT)

Stock Analyzer, OTCPicks, QualityStocks, SmallCapVoice, PennyTrader Publisher, Penny Stock Rumble, StockHideout, OTC Picks and AllPennyStocks reported earlier on All American Pet Company (AAPT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

All American Pet Company, Inc. (OTC: AAPT) is focused on the production, development, marketing and sale of pet wellness products, with a focus on dogs.

The firm has its headquarters in Los Angeles, California and was incorporated in 2003, on February 13th by Barry Schwartz and Lisa Bershan. It operates as a shell company as part of the other miscellaneous manufacturing industry. The firm serves consumers in the United States.

The company provides nutritional dog food bars under the Nutra Bars brand; mineral and vitamin bars under the Chomp Bar brand name; and anti-bacterial alcohol-free dog cleaner products like pet sprays and wipes under the Pawtizer name. In addition to this, it also offers Chewies dog snacks and Mutt pet food products. It markets its product through supermarkets and other retailers.

The enterprise’s Mutt Bars are supplemented with energizing fats, minerals, vitamins and contain 25% super premium chicken protein while its Chewies products are 100% wheat gluten-free and contain no by-products. Chewies are also all natural, nutrient dense and rich in proteins and come in the peanut, cheese and bacon flavors. On the other hand, Chomp bars come in the following varieties: a senior formula offering joint support, a low-fat formula and 25% original protein. NutraBars are also rich in proteins, in addition to being non-GMO, gluten-free and a taste-tacular treat.

The company recently concluded its acquisition of Kuora Industrial Interconnect. This move positions the company well for growth in the near future given its strategic partnerships, which may also have a positive influence on investments.

All American Pet Company (AAPT), closed Wednesday’s trading session at $0.0208, off by 3.7037%, on 53,623,435 volume.The average volume for the last 3 months is 50.321M and the stock's 52-week low/high is $0.00005/$0.0365.

Alpha Esports Tech Inc. (APETF)

We reported earlier on Alpha Esports Tech Inc. (APETF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alpha Esports Tech Inc. (OTC: APETF) (CNSX: ALPA) (FRA: 9HN) is a technology firm that is focused on emerging markets in the blockchain, e-commerce, mobile gaming, e-sports and other high growth opportunity segments.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2019, on March 1st. Prior to its name change in December 2020, the firm was known as Alpha Esports Inc. The firm serves consumers around the globe.

The company is dedicated to diversity, innovation and the implementation of the highest standards of the technical method. It is focused on providing intellectual property and cutting-edge technology through its range of quality-controlled, standardized formulated products. The company is committed to transforming the future of esports through the use of its technology to break down stereotypical barriers to gaming, while also uplifting and empowering the gaming community.

The enterprise operates and owns a subscription-based service known as GamerzArena+ which mostly caters to higher-paying tournaments; and an online platform known as GamerzArena, where gamers can watch and play games. This platform, which has been designed to help gamers achieve a sense of competition, allows gamers to take part in every day tournaments as well as compete with their peers. This is in addition to facilitating the live-streaming of its players’ gameplay for others to view.

The company recently entered into a partnership agreement with Nets Gaming Crew, which will afford the company the opportunity to connect with Net’s fans. This is in addition to boosting the company’s growth and development, which is bound to bring in more investors into the company.

Alpha Esports Tech Inc. (APETF), closed Wednesday’s trading session at $0.2653, up 3.4954%, on 24,946 volume.The average volume for the last 3 months is 53.623M and the stock's 52-week low/high is $0.011/$0.7656.

Avicanna Inc. (AVCNF)

We reported earlier on Avicanna Inc. (AVCNF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Avicanna Inc. (OTCQX: AVCNF) (TSE: AVCN) (FRA: 0NN) is a biopharmaceutical firm that is focused on the development and sale of plant-derived cannabinoid-based products, with a focus on South and North America.

The firm has its headquarters in Toronto, Canada and was incorporated in May 2015, by Setu Purohit, Kyle Langstaff and Aras Azadian. It serves consumers around the globe.

The company is party to a research collaboration with Dr. Christine Allen’s Research Group, which entails the development of a CBD-based treatment for the lung inflammation linked with the coronavirus, which is caused by the SARS-Cov-2 virus. It operates through the Cultivation and the Research and development segments. The cultivation segment is involved in the control of two companies found in Colombia which have been permitted to cultivate and process marijuana for the production of extracts like CBD and THC. On the other hand, the research and development segment carries out business in the Johnson & Johnson Innovation center.

The enterprise develops pharmaceutical products for palliative care ailments, arthritis, neuropathic pain, multiple sclerosis, Parkinson’s disease, epilepsy, sleep disorders, depression and anxiety, acne, eczema and epidermolysis bullosa. This is in addition to providing THC seeds, cannabigerol and cannabidiol under the Avesta Genetica brand name. In addition to this, it offers wellness and medical products which include transdermal, topical, sublingual and oral deliveries under the Rho Phyto brand.

The firm recently completed its first commercial exports of its proprietary genetics in the form of feminized marijuana seeds to Argentina and Peru. These long-term medicinal marijuana cultivation programs will help extend the firm’s consumer reach and encourage more investments into the company.

Avicanna Inc. (AVCNF), closed Wednesday’s trading session at $0.6669, off by 0.04796%, on 200 volume.The average volume for the last 3 months is 24,946 and the stock's 52-week low/high is $0.5886/$2.50.

Cyberlux Corp. (CYBL)

OTC Picks, OTCPicks, Stock Stars, Trades Of The Day, Stockpalooza, Stock Source and Innovative Marketing reported earlier on Cyberlux Corp. (CYBL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cyberlux Corp. (OTC: CYBL) is an advanced lighting technology firm that is focused on the design, development and marketing of portable lighting products for industrial and commercial users.

The firm has its headquarters in Durham, North Carolina and was incorporated in 2000, on May 17th. It operates as part of the semiconductor and other electronic component manufacturing industry. The firm serves consumers in the United States.

The company carried out its business through outsourcing relationships with professionals who are specialists. It serves consumers from various industries like design services customers, as well as commercial, government and military organizations like Homeland Security, the military and the Department of Defense.

The enterprise offers portable LED lighting systems for security and equipment maintenance, forward-based operations and special operators. It also offers its consumers custom application engineering and support, which includes power and thermal management, mechanical and software solution design and rapid prototyping. Its products include the solar power charging system, Best BrightEye solar-powered trailer-mounted lighting system, Advanced spectrum lighting system, NightEye Expandable tent light, NightEye shelter lighting system, the Watchdog, WhiteEye portable lighting system, BrightEye portable illumination system and the BrightEye 4M tower illumination system. The enterprise’s BrightEye illumination systems address the lighting needs of different branches of the military and a few government organizations.

The firm recently established its drone business unit via the acquisition of CTMC Drone Solutions LLC, which will help increase the adoption as well as the revenue for the firm’s products. This acquisition may also help extend the firm’s consumer reach, which will be good for its investments.

Cyberlux Corp. (CYBL), closed Wednesday’s trading session at $0.0314, off by 14.9051%, on 505,617,039 volume.The average volume for the last 3 months is 200 and the stock's 52-week low/high is $0.000001/$0.066.

Resonant (RESN)

StockMarketWatch, TraderPower, Kiplinger Today, MarketBeat, TradersPro, InvestorPlace, MarketClub Analysis, BUYINS.NET, Stock News Now, StreetInsider, Wall Street Mover, Wall Street Resources, Wealth Insider Alert, StockOodles, Zacks, The Best Newsletters, The Online Investor, Short Term Wealth, QualityStocks, Trades Of The Day, Market FN, Investing Futures, Market Report and Stock Market Watch reported earlier on Resonant (RESN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Resonant Inc. (NASDAQ: RESN) (FRA: 2EK) is a development firm that is engaged in designing and developing filters for front end and radio frequencies utilized in internet-of-things, medical, automotive and mobile devices, as well as related industries in China, Japan and across the globe.

The firm has its headquarters in Austin, Texas and was founded in January 2012 by Robert B. Hammond and Neal Fenzi. It operates in the technology sector under the tech hardware and semiconductors industry.

The enterprise utilizes a software platform dubbed Infinite Synthesizes Networks technology, which allows the configuration and connection of resonators that build RF Filter blocks to reject unwanted signals and select desired radio frequency signals. It’s also involved in the development of a technology for non-mobile and mobile applications known as XBAR, including Ulta-WideBand applications, WiFi and 5G.

It is currently using ISN to create new filter design classes. This is in addition to being engaged in the development of multiplexer filter designs for more than 2 bands to address CA requirements (carrier aggregation) of its consumers and single-band surface acoustic wave filter designs (SAW) for frequency bands. The firm is also designing reconfigurable filter designs for multiple bands to replace multiple filters. Additionally, it is also developing a filter that can be reconfigured between 3 bands.

The company recently relocated to Texas, with its CEO explaining that the move would be beneficial to the company’s growth while they work to expand their global footprint. Their financial results for 2021’s first quarter also show that the company expanded its patent portfolio while extending its licensing agreement with its Chinese partner to service the growing mobile handset market in China. This will boost investments into the firm, which will be beneficial to its stakeholders.

Resonant (RESN), closed Wednesday’s trading session at $2.58, up 20%, on 5,632,526 volume.The average volume for the last 3 months is 505.617M and the stock's 52-week low/high is $2.09/$8.33.

Sphere 3D (ANY)

StockMarketWatch, MarketClub Analysis, TradersPro, BUYINS.NET, QualityStocks, Fierce Analyst, Small Cap Firm, Profitable Trader Authority, PennyStockProphet, Penny Pick Finders,, PoliticsAndMyPortfolio, MarketBeat, HotOTC, Buzz Stocks, OTCtipReporter, TraderPower, The Street, StockWireNews, StreetInsider, The Best Newsletters, Broad Street, Wall Street Mover, TopPennyStockMovers, Hit and Run Candle Sticks, Market Report, InvestorPlace, InvestorsUnderground, PennyStockScholar, The Observer, Promotion Stock Secrets, OTC Markets Group, StockStreetWire, Pennybuster, Barchart, StockOnion, Zacks, Schaeffer's and Market FN reported earlier on Sphere 3D (ANY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sphere 3D Corporation (NASDAQ: ANY) (FRA: 8S3B) is a firm that is engaged in the provision of application and desktop virtualization and data management solutions in the Asia Pacific, Africa, Middle East, Europe and the Americas.

The firm has its headquarters in Toronto, Canada and was founded in 2007. It generates its revenue mainly from solutions for customer and warranty services, professional services, integrated hyper-converged storage and standalone storage services. It caters to the cloud computing market and sells its products through reseller and distributor networks to distributed enterprises as well as medium and small businesses.

The company enables organizations to deploy various hybrid, private or public cloud strategies while backing them up with advanced storage solutions at affordable rates. Additionally, together with Tandberg Data and Overland Storage, which are its wholly-owned subsidiaries, Sphere 3D has a portfolio of brands which include V3, NEO, SnapSync, SnapServer, SnapCloud, Classware 2.0 and RDX.

The enterprise provides hyper-converged and HVE converged infrastructure solutions like a virtualized desktop infrastructure solution dubbed HVE 3DGFX; a dual enclosure storage area network known as HVE-VELOCITY and the HVE STACK high density server solution. This is in addition to providing G-series appliances to simplify Windows application migration and allow access from other devices. The company gives investors interested in these market segments opportunities to grow their money.

Sphere 3D (ANY), closed Wednesday’s trading session at $6.9, up 11.2903%, on 54,460,463 volume.The average volume for the last 3 months is 5.633M and the stock's 52-week low/high is $1.23/$11.98.

Farmmi (FAMI)

StreetInsider, StockMarketWatch, QualityStocks, StockOnion, Profitable Trader Authority, PennyStockScholar, PennyStockProphet, Penny Pick Finders, OTCtipReporter, Money Morning, HotOTC and Buzz Stocks reported earlier on Farmmi (FAMI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Farmmi Inc. (NASDAQ: FAMI) is a supplier of agricultural products and together with its subsidiaries, is engaged in the processing and sale of agricultural products in the Middle East, Korea, Europe, Canada, Japan, the United States and China. Farmmi Inc.’s objective is to build a worldwide trading platform for agricultural goods.

The company has its headquarters in Lishui city, in the People’s Republic of China and was established in 2003 by Zheng Yu Wan and Ye Fang Zhang. The firm, which operates in the consumer goods sector, went public on February 16, 2018.

Farmmi Inc. provides its products which are green, organic and sustainable, to local specialty stores, cafeterias and restaurants, as well as through distributors. The firm manages an industry chain of internet marketing for agriculture products with agricultural technology research and development, product processing and family farm development.

Farmmi Inc. provides Mu Er mushrooms, shiitake and other edible fungi products such as hericium erinaceus, coprinus comatus, grifola frondosa, pleurotus eryngii, agrocybe aegerila and bamboo fungi. This is in addition to tea, nuts, fruits, beans and rice. The firm also operates Farmmi Jicai, an online store that sells edible fungi products under the Farmmi Liangpin and Forasen brands.

Farmmi Inc., through its Zhejiang Forest Food Co. Ltd. subsidiary, recently won a multi-product U.S. export order for their dried black fungus and mushrooms, which is sought after by various global supermarket and hotel chains, such as the Stanford Hotel. The firm is now allowed to export its products to the U.S. which will not only broaden its reach but also boost its growth.

Farmmi (FAMI), closed Wednesday’s trading session at $0.3938, up 21.3559%, on 365,372,185 volume.The average volume for the last 3 months is 54.311M and the stock's 52-week low/high is $0.1955/$2.47.

Acer Therapeutics (ACER)

StockMarketWatch, MarketBeat, BUYINS.NET, MarketClub Analysis, StreetInsider, Schaeffer's, Zacks, PennyStockProphet, Buzz Stocks, Daily Trade Alert, Hototc, Barchart, Penny Pick Finders, PennyStockScholar, Profitable Trader Authority, QualityStocks, StockOnion and OTCtipReporter reported earlier on Acer Therapeutics (ACER), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Acer Therapeutics Inc. (NASDAQ: ACER) (FRA: P6NA) is a pharmaceutical firm that is engaged in acquiring, developing and commercializing therapeutics for the treatment of severe, rare and life-threatening ailments such as maple syrup urine diseases and vascular Ehlers-Danlos syndrome.

Acer Therapeutics serves consumers in the United States and is based in Newton, Massachusetts. The firm, formerly known as Opexa Therapeutics Inc., was founded on March 15, 1991. The company was acquired by Acer Therapeutics, which was privately owned. The two merged resulting in the formation of Acer Therapeutics Inc.

Acer Therapeutics Inc. is party to a license agreement with Sanofi to obtain global rights to a selective, clinical-stage non-peptide NK3 receptor agonist known as osanetant and party to a research collaboration agreement with the National Center for Advancing Translational Sciences which entails the development of emetine hydrochloride as a possible treatment for coronavirus patients.

The Acer Therapeutics Inc. product portfolio includes ACER-2820, a therapy indicated for the treatment of various infectious ailments, including the coronavirus; ACER-801, which has been developed as a treatment for induced Vasomotor symptoms; ACER-001, which is indicated for the treatment of inborn metabolism errors such as maple syrup urine disease (MSUDs) and urea cycle disorders (UCDs); and EDSIVO, which has been indicated as a treatment for vascular Ehlers-Danlos syndrome in patients who have a confirmed type 3 collagen mutation. The firm is also developing Tovaxin, a T-cell vaccine indicated for the treatment of multiple sclerosis.

Acer Therapeutics Inc. and Relief Therapeutics Holding AG recently signed an option agreement that would provide them with exclusivity to negotiate a license and collaboration agreement for the global development and commercialization of the firm’s ACER-001 candidate. This move would help patients globally who suffer from debilitating diseases like MSUD and UCDs have access to treatment while addressing a previously unmet medical need.

Acer Therapeutics (ACER), closed Wednesday’s trading session at $2.9, up 16.4659%, on 13,127,488 volume.The average volume for the last 3 months is 363.558M and the stock's 52-week low/high is $2.28/$5.39.


StockMarketWatch, TraderPower, StocksImpossible, OTCBB Journal, Buzz Stocks, MarketBeat, MarketClub Analysis, RedChip, Penny Pick Finders, PennyStockProphet, Profitable Trader Authority, BUYINS.NET, StockOnion, Bull Trends, PennyStockScholar, OTCtipReporter, First Penny Picks, QualityStocks, StreetInsider, Stock Beast, Planet Penny Stocks, StockPicksNYC, AwesomeStocks, Broad Street, The Street, Greenbackers, HotOTC, Investor Ideas, MegaPennyStocks, Penny Stock General, Schaeffer's, StockHideout, Shiznit Stocks, Small Cap Firm, Barchart, Short Term Wealth, TopPennyStockMovers,, Tiny Gems, CrashTrade, SecretStockPromo, StockRockandRoll, InvestorPlace, PennyStockLocks, TradersPro,, Street Insider, AllPennyStocks, Stock News Now, SmallCapVoice, StockOodles, Penny Stock 101 and smartOTC reported earlier on NXT-1D (NXTD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NXT-ID Inc. (NASDAQ: NXTD) (FRA: ONI1) is a development stage technology firm that provides technology services and products for various healthcare applications

NXT-ID Inc. is based in Oxford, Connecticut and was founded on February 8, 2012 by David Charles Tunnell and Gino Miguel Pereira. The firm operates in one software and hardware security systems and applications segment. The firm serves various end markets, include the IoT (Internet of Things), financial technology, healthcare and security markets.

NXT-ID Inc. is involved in manufacturing and distributing monitored and non-monitored personal emergency response systems through its LogicMark LLC subsidiary, which is wholly-owned. The systems are sold through the U.S. Department of Veterans Affairs as well as through distributors and dealers.

NXT-ID Inc. develops and markets solutions for Internet of Things, payment and healthcare applications with experience in sensor technologies, miniaturization, payments, encryption and data protection, security and privacy, behavior-metric and biometric identity verification and access control. The firm’s technology products include a digital credit card that was developed in partnership with WorldVentures dubbed Flye; a next-generation smart wallet called the Wocket and a suite of biometric solutions that secure customers’ mobile platforms known as MobileBio.

The company announced recently that its LogicMark LLC subsidiary would begin field testing of its WIFINotifi device, which will help expand the firm’s revenue reach into different revenue channels.

NXT-1D (NXTD), closed Wednesday’s trading session at $0.4032, up 17.6539%, on 75,390,644 volume.The average volume for the last 3 months is 51,710 and the stock's 52-week low/high is $0.29/$3.44.

Catalyst Pharmaceuticals, Inc. (CPRX)

Wall Street Resources, The Street, StreetInsider, MarketBeat, MarketClub Analysis, StockMarketWatch, Streetwise Reports, Stock Analyzer, TraderPower,, InvestorPlace, PennyOmega, BUYINS.NET, StockOodles, PennyStocks24, OTC Picks, Momentum Traders, DrStockPick, OTCPicks, AllPennyStocks, SmallCapVoice, MicroCapINPLAY, PennyTrader Publisher, StockHotTips, MicrocapVoice, FeedBlitz, Penny Stocks VIP, Microcapmillionaires, CRWEPicks, BestOtc, CRWEFinance, Schaeffer's, CRWEWallStreet, QualityStocks, PennyToBuck, Hit and Run Candle Sticks, Dynamic Wealth Report, Greenbackers, Daily Markets, CoolPennyStocks, BullRally, Daily Trade Alert, Barchart, Market Report, HotOTC, PennyStockVille, Trades Of The Day, Street Insider, Stocks That Move, StockRich, StockEgg, Stock Stars, Rick Saddler, OTCtipReporter, Promotion Stock Secrets, Investopedia, PennyStockScholar, PennyInvest, Penny Stock Rumble, Zacks, Penny Stock Prodigy, MonsterStocksPicks, MadPennyStocks and RedChip reported earlier on Catalyst Pharmaceuticals, Inc. (CPRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company headquartered in Coral Cables, Florida. It concentrates on developing and commercializing unique therapies for people with rare debilitating, chronic neuromuscular, as well as neurological diseases. The Company was previously known as Catalyst Pharmaceutical Partners, Inc. It changed its corporate name to Catalyst Pharmaceuticals, Inc. in May of 2015. Established in 2002, Catalyst Pharmaceuticals’ shares trade on the NasdaqGS.

The Company has launched amifampridine. This is the only evidence-based, FDA (Food and Drug Administration)-approved treatment for adult patients with Lambert-Eaton Myasthenic Syndrome (LEMS). It is the first product approved by the FDA for LEMS in over 35 years. For that approval, Catalyst Pharmaceuticals successfully completed two Phase 3, multicentered clinical trials of amifampridine in patients with LEMS.

At present, the Company is completing a Phase 3 trial examining the efficacy and safety of amifampridine in patients with MuSK-positive myasthenia gravis (MuSK-MG) after an earlier successful proof-of-concept study of amifampridine in the same population. Moreover, Catalyst Pharmaceuticals is preparing to initiate earlier stage clinical trials of amifampridine in other ultra-rare neuromuscular conditions.

Last month, Catalyst Pharmaceuticals and KYE Pharmaceuticals, Inc. announced that the companies entered into an exclusive license agreement under which KYE will commercialize Firdapse® in Canada. Firdapse® is indicated for the symptomatic treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. With this agreement, Catalyst Pharmaceuticals will supply Firdapse® to KYE and KYE will be responsible for promotion, sales, advertisement, marketing, product importation, as well as distribution.

Furthermore, KYE Pharmaceuticals will be responsible for the continuing maintenance of the regulatory file and future communications with Health Canada. KYE is a private company based in Mississauga, Ontario. KYE focuses on bringing medicines that fulfill clinically significant unmet needs to the Canadian market.

In August, Catalyst Pharmaceuticals announced that Canada’s national healthcare regulatory agency, Health Canada, approved the use of Firdapse® (amifampridine) for the treatment of patients in Canada with Lambert-Eaton myasthenic syndrome (LEMS).

Catalyst Pharmaceuticals, Inc. (CPRX), closed Wednesday’s trading session at $6.12, up 10.4693%, on 1,750,131 volume.The average volume for the last 3 months is 75.391M and the stock's 52-week low/high is $2.875/$6.235.

Computer Task Group, Inc. (CTG)

Streetwise Reports,, StreetInsider, MarketBeat, The Wall Street Transcript, StockMarketWatch, MicroCap Gems, Vantage Wire, StocksJournal, Stockhouse, QualityStocks and AllPennyStocks reported earlier on Computer Task Group, Inc. (CTG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Earnings Preview

Computer Task Group (NASDAQ: CTG) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Expect Increased Traction Of CTG’s Digital Solutions Work To Fuel Year-To-Year Revenue, Margin And EPS Gains In 3Q:21, Excluding A 3Q:20 Tax Benefit; Our $14 Target Implies Meaningful Upside”

Click here to access the full report

CTG is a leading provider of digital transformation solutions and services that accelerate clients’ project momentum and achievement of their desired IT and business outcomes. We have earned a reputation as a reliable, results-driven partner focused on improved data-driven decision making, meaningful business performance improvements, new and enhanced customer experiences, and continuous innovation. CTG has operations in North America, South America, Western Europe, and India. For more information, visit the company’s website at

Computer Task Group, Inc. (CTG), closed Wednesday’s trading session at $8, even for the day, on 21,336 volume.The average volume for the last 3 months is 1.75M and the stock's 52-week low/high is $4.68/$11.68.

The QualityStocks Company Corner

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER)

The QualityStocks Daily Newsletter would like to spotlight The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER).

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER)the country’s largest independent alkaline water company, has announced that Sam’s Club will carry its Alkaline88(R) single-serve, one-Liter 12-pack offering in all 587 locations in the continental U.S. The product will be available by early November. The company stated that the agreement was possible because of its increased supply chain and production capabilities, including four new co-packers working to support WTER’s expected increase in volume. The single-serve, one-liter is the first of WTER’s products available in the all-important club channel, but the company hopes more of its offerings will follow. A leading membership warehouse club with nearly 600 clubs and millions of members in the United States and Puerto Rico, Sam’s Club offers a milestone moment for the company. “Alkaline88’s presence in Sam’s Club marks another milestone for our company and its stockholders,” said The Alkaline Water Company president and CEO Ricky Wright in the press release. “Sam’s Club is known for offering superior products and savings to their members. They are one of the largest membership warehouse clubs with millions of members nationwide. Beginning in November, members will find Deliciously Smooth(TM) Alkaline88 one-liters in a convenient 12-pack in their local Sam’s Club. The increased sales of our single serves this fiscal year will accelerate even more with this major win.” To view the full press release, visit

Founded in 2012, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88®, is a leading premier alkaline water brand available in bulk and single-serve sizes, along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88® delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked label ‘Clean Beverage’. Quickly being recognized as a growing lifestyle brand, Alkaline88® launched A88 Infused™ in 2019 to meet consumer demand for flavor-infused products. A88 Infused™ flavored water is available in six unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched the A88CBD™ brand, featuring a broad line of topical and ingestible products. These products are made with lab-tested full and broad-spectrum hemp and include salves, balms, lotions, essential oils, bath-salts, CBD infused drinks, tinctures, capsules, gummies and powder packs.

Innovation and Expansion

Founded in 2012, The Alkaline Water Company began with a mission to create the best-tasting water in the world. At the time, there were two emerging trends in health-conscious consumers: a growing interest in the alkaline diet and perceived health benefits of pink Himalayan rock salt. By combining these two concepts in an alkaline water and trademarking the name Alkaline88, The Alkaline Water Company began offering what it calls the smoothest tasting Clean Beverage™ in the U.S. enhanced-water category.

Now a top bulk alkaline-water brand (the company reported record sales in March and April 2020, surpassing March and April 2019 numbers by 114% and 171%, respectively), The Alkaline Water Company is committed to growing its national footprint through innovation and expansion. That mindset was evident as the company introduced eco-friendly aluminum bottles and branched out into flavor-infused waters; the company currently offers six different flavors: peach/mango, lemon/lime, raspberry, watermelon, blood orange and lemon.

The company’s commitment to innovation may be most evident in its newest product line: A88CBD. This line of CBD-infused products includes tinctures, capsules, gummies, salves, balms, hand and foot lotions, essential oils, bath bombs and bath salts, as well as CBD-infused drinks, water and beverage shots. These quality, CBD-infused offerings are all made with lab-tested, full-spectrum hemp and are conveniently packaged and perfect for on-the-go or at home use.

In addition, The Alkaline Water Company has implemented an aggressive growth strategy, with numerous organic initiatives focused on national multichannel, mass-market expansion through a direct-to-warehouse model and co-packing facilities that are strategically located within 600 miles of 95% of the U.S. population. In addition to this strong brick-and-mortar approach, the company recently launched a B2C e-commerce platform ( and aggressive digital-marketing campaigns.

Clear Advantages in a Growing Market

With consistent growth year over year, the company reported $32.2 million in revenue in fiscal 2019 and has emerged as a growth leader in the functional (value-added) waters space, which is the fastest-growing segment of the bottled water industry.

The Alkaline Water Company’s efforts are focused on its clear competitive advantages, including its strong marketing (the inclusion of alkaline in product names); existing grocery channels, which feature excellent relationships and a nationwide broker network; distinctive branding; proprietary technology, which produces great-tasting, high-quality water, infused drinks and other products; and price, with a broad range of products in all formats, from bulk bottles to single serve.

As the company focuses on strategic growth, it is eyeing the impressive potential of a market that is on a strong upswing. Annual bottled water sales have now surpassed soda consumption, with soda sales in the United States having declined by $1.2 billion over the past five years. Some research indicates that the global bottled water market will reach an estimated $280 billion this year, while the CBD market is forecast to top $20 billion by 2024.

With its products available in all major trade channels, including grocery stores, drug stores, c-stores and big-box retailers, The Alkaline Water Company is also looking to expand into new spaces, such as health and beauty, hospitality and specialty retailer locations.

Seasoned Management Team

The Alkaline Water Company is led by an experienced team focused on the company’s core strategy of building a national retail footprint and extending its lifestyle brands into other consumer packaged goods categories.

Richard A. Wright, President, CEO and Co-Founder of The Alkaline Water Company Inc., oversees all aspects of the business, successfully guiding the company through strategic opportunities and delivering greater than 50% growth since the company’s inception. A passionate and versatile leader with a strong track record of innovation, collaboration and achieving goal-driven results, Wright is a serial entrepreneur with more than 41 years of experience. Early in his career, he spent years at one of the ‘Big Four’ accounting firms, working his way up to Regional Director of Tax and Financial Planning. As a CPA, entrepreneur and former CFO, Wright brings extensive knowledge of finance, operations, sales and marketing to the team, and he has participated in hundreds of M&A transactions throughout his career.

David Guarino, CFO, Secretary, Treasurer and Director, earned a Bachelor of Science in accounting and a Master of Accountancy from the University of Denver. From 2008 to 2013, Guarino was President and a Director of Kahala Corp., a worldwide franchisor of multiple quick-service restaurant brands with locations in 49 states and more than 25 countries. From 2014 to 2015, Guarino was President of HTI International Holdings Inc., a technology company focused on forward osmosis water filtration technology.

Frank Chessman, National Sales Manager, is a graduate of the University of Southern California’s Marshall School of Business. He spent 25 years with Ralph’s Grocery, Kroger’s largest division, working at many levels before ultimately becoming Vice President of Advertising & Marketing. He then served 14 years as Executive Vice President at Simon Marketing. Chessman has more than a decade of experience in the beverage manufacturing industry.

Brian Sudano, Director, is managing partner of Beverage Marketing Corporation and BMC Strategic Associates. Sudano’s experience covers nearly the entire beverage industry, from energy drinks to wine, with special expertise in beverage alcohol by virtue of varied industry experience across a broad range of projects. Sudano manages several major clients, providing ongoing strategic and market advice and leading projects in strategic planning, market entry analysis and planning, sales/distribution, business modeling, brand repositioning and international opportunity assessment. He has spoken at many beverage industry events and is a contributing editor at Beverage World magazine.

Aaron Keay, Chairman, has been a successful investor, entrepreneur and financier to multiple small cap and startup companies over the last decade. During his time with these companies, he served in advisor, board-member and senior-management roles. His experience ranges across multiple sectors in mining, biotech, health and wellness, tech and cannabis, where he has invested and raised more than $500 million.

The Alkaline Water Company Inc. (NASDAQ: WTER), closed Wednesday’s trading session at $1.57, up 10.5634%, on 3,766,085 volume.The average volume for the last 3 months is 9,624 and the stock's 52-week low/high is $0.93/$2.35.

Recent News

Kaival Brands Innovations Group Inc. (KAVL)

The QualityStocks Daily Newsletter would like to spotlight Kaival Brands Innovations Group Inc. (KAVL).

Kaival Brands (NASDAQ: KAVL), the exclusive global distributor of products manufactured by Bidi Vapor LLC, announced that it will attend and exhibit in person, along with Bidi Vapor, at the 2021 NACS show. The event kicked off, after a two-year COVID hiatus, on Oct. 5 at McCormick Place in Chicago, Illinois. “We are excited to attend the first in-person NACS event since the start of the COVID-19 pandemic. Previously, the NACS show served as a significant catalyst for new client introductions and new orders,” said Niraj Patel, founder and chief executive officer of Kaival Brands. “We are looking forward to catching up with industry connections in person, and forming new relationships, both domestically and internationally, while at the conference and expo.” To view the full press release, visit

Kaival Brands Innovations Group Inc. (KAVL) is focused on growing and incubating innovative and profitable products into mature, dominant brands. It aims to develop internally, acquire or exclusively distribute these products, helping them grow into market-share leaders by providing superior quality that is recognizable in their individual industries.

Formerly known as Quick Start Holdings Inc., the company changed its name to Kaival Brands Innovations Group Inc. (also known as Kaival Brands) in July 2019. Headquartered in Grant, Florida, the company commenced business operations on March 9, 2020.

Bidi™ Stick – Revolutionizing the Vaping Experience

On March 9, 2020, Kaival Brands entered into a partnership with Bidi Vapor LLC. The latter granted Kaival Brands exclusive global distribution rights for the innovative Bidi™ Stick.

Bidi™ Stick is a completely self-contained disposable product that is tamper-proof and recyclable. The innovative product is made from high-quality components and equipped with a long-lasting battery and class A nicotine. Its product engineering also includes a sensitivity control system, along with a proven mechanism designed to help identify and eliminate counterfeit products.

Available in 11 flavors, the Bidi™ Stick offers a premium vaping experience for adult consumers only. From its packaging design to its marketing strategies, Bidi Vapor makes sure that everything is compliant with government regulations.

On March 31, 2020, Kaival Brands partnered with QuikfillRx Digital as a digital service provider to help promote and commercialize the Bidi™ Stick. As a direct result of the partnership, Kaival Brands received back-to-back orders for the vaping device, totaling approximately $135,000, from sizable national convenience chains.

On September 8, 2020, the company announced that Bidi Vapor had submitted its Premarket Tobacco Product application (PMTA) to the U.S. Food and Drug Administration (FDA) for review. In total, over 285,000 pages of research, studies and surveys were submitted to support the application of Bidi™ Stick’s 11 variants.

“We are confident that, upon review, the FDA will authorize Bidi Vapor’s Bidi™ Stick for continued marketing in the United States,” Niraj Patel, President and CEO of Kaival Brands, stated in a news release (

Bidi Vapor is an industry leader in recycling – a position that was furthered through the creation of the Bidi Cares Initiative. The program encourages users to recycle their used Bidi™ Sticks instead of trashing them. As motivation, Bidi Vapor offers a free Bidi™ Stick for every 10 used devices recycled by a consumer. Kaival Brands is the exclusive recycling provider for the initiative.

Partnership Impact and Market Outlook

Bidi Vapor is a related party to Kaival Brands, as it is owned by Kaival Brands CEO Nirajkumar Patel. Patel is also the majority stockholder of Kaival Brands, placing both entities under common control.

The partnership has already had a positive impact on Kaival Brands, helping the company expedite growth, as evidenced by its Q2 financial results. According to Kaival Brands’ consolidated fiscal results for the quarter that ended on April 30, 2020, its revenues grew to approximately $22.5 million from no revenue in the same quarter of 2019. The company also scored a gross profit of $4.2 million for the three-month period. Net income was reported at $2.8 million for the quarter, compared to a net loss of about $4,000 in the second quarter of 2019. The company ended the second quarter of 2020 with a cash balance of $2 million (

The positive results are primarily an effect of Bidi™ Stick distribution amid the growing worldwide demand for high-quality vape products, as Patel explained in a news release. “Our focus now is to continue to increase revenues by increasing Bidi Vapor’s market share in the vaping industry,” he added.

Internationally, Kaival Brands has already taken steps to expand distribution of the Bidi™ Stick into Guam, Canada, the European Union, the United Kingdom, Australia and New Zealand.

To this end, the company has set up a market engagement and sales force to reach a higher volume of retail and wholesale customers. It also created a dedicated customer support team to provide high-quality service and an enhanced customer experience.

Kaival Brands is dedicated to developing innovative and viable options for adults who use tobacco and vape products and want a premium experience. The company wants to set higher standards to transform perceptions and elevate consumer experience in the vape and CBD industries, with a goal of increasing market share in the ever-growing vaping industry. In 2019, the reported global market for the vaping industry alone was $12.4 billion. These forecasts indicate a potential CAGR of 23.8% through 2027.

Cancellation of 300 Million Shares of Common Stock

In August 2020, the company canceled 300 million shares of common stock, marking a 52.1 percent reduction in its issued and outstanding shares of common stock ( Currently, the company’s outstanding common shares total 277,282,630. The cancelation was done in exchange for three million shares of Series A Preferred Stock. The Series A Preferred Stock cannot be converted before November 2023, barring any event that may trigger early conversion.

According to Patel, this move will benefit all shareholders and help maintain stability of the market pricing of remaining common stock. The overall goal is to increase value for long-term investors.

Management Team

Nirajkumar Patel is the CEO, CFO, President, Treasurer and Director of Kaival Brands and owner of Bidi Vapor LLC. In 2004, Patel received a Bachelor of Science in pharmaceutical sciences from AISSMS College of Pharmacy in Prune, India. He moved to the United States in 2005, and he continued his education at the Florida Institute of Technology, where he graduated in 2009 with a master’s degree in medicinal and pharmaceutical chemistry. He currently holds a Six Sigma Black Belt Certification.

Eric Mosser is the COO, Secretary and Director of Kaival Brands. Mosser attended Arizona State University, where he studied business management. In 2004, he graduated from Rio Salado College with an associate degree in applied science in computer technology.

Kaival Brands Innovations Group Inc. (KAVL), closed Wednesday’s trading session at $1.39, up 3.7313%, on 648,223 volume.The average volume for the last 3 months is 3.761M and the stock's 52-week low/high is $1.21/$43.80.

Recent News

DSG Global Inc. (OTCQB: DSGT)

The QualityStocks Daily Newsletter would like to spotlight DSG Global Inc. (DSGT).

DSG Global (OTCQB: DSGT) today announced that its Canadian electric vehicle division, Imperium Motor Company Canada, finished a successful Quebec Electric Vehicle event this past weekend. According to the update, the show resulted in significant exposure and media coverage, and Quebec Journalists experienced test drives of the SEV after the show with articles and TV reviews to follow. The enthusiastic consumer response to seeing and experiencing the SEV in person for the first time resulted in deposits on over 327 SEVs during the Montreal and Quebec shows for retail sales of approximately $15 million. Journalist and radio personality Benoit Charette reported that the SEV stole the show. To view the full press release, visit

DSG Global Inc. (OTCQB: DSGT) is an emerging global technology company with interconnecting businesses in fast growing market sectors. With roots in the golf industry, the company specializes in golf fleet management and is moving quickly into road-ready electric vehicles for delivery in the third quarter of 2021.

In 2019, the company secured exclusive North America distribution rights for Jonway Automobile Co. road-ready electric vehicles (EVs). Jonway, based in Zhejiang, China, began manufacturing new vehicles s in 2003 and today produces Electric powered Cars, Trucks, Vans, SUV’s, and Scooters. Jonway vehicles are exported to more than 80 countries and are built to comply with U.S. safety and environmental standards.

These vehicles are being sold via DSG’s wholly owned subsidiary, Imperium Motor Company (IMC). The move into consumer vehicles capitalizes on the company’s strength in the selection and distribution of EVs, the ability to work with large manufacturers and in application of proprietary technology unique to DSG. DSG’s advanced fleet tracking can be integrated into Jonway EVs to offer a customized scalable and integrated solution to meet the needs of small businesses and large enterprises.

The Future is Electric

With decades of EV experience in golf, including distribution of highly advanced carts, DSG recognized the huge chasm between consumer interest in acquiring road ready EVs versus current EV models’ lack of availability and affordability. As such, the company focused on becoming a distribution and EV brand management company unencumbered by the manufacturing process. The manufacturers take responsibility for building vehicles to DSG’s specifications and fulfillment of regulatory and licensing requirements.

DSG has also established a distribution agreement with Skywell New Energy Automobile Group Ltd., an Asian-based EV manufacturer. Skywell will supply DSG with SUV’s, Passenger Vans, Cargo Vans, Commercial Vehicles and Buses that will be fully certified for use in the United States.


Imperium Motor Company (IMC) seeks to transform the way the world drives by making greener transportation available to everyone. IMC is an EV sales and marketing company that distributes directly to consumers and through third party distributors, offering a wide variety of affordable vehicles equipped for the North American market. The company’s emphasis is on great design, a green mindset, performance and functionality. Its vehicles include 26 models of high-speed, mid-speed and low-speed electric vehicles including cars, trucks, SUVs, vans, buses and scooters.

Vantage Tag Systems (VTS) is a global leader in the design, manufacture, and marketing of fleet management solutions for the golf industry. VTS has developed the TAG suite of products that represents the industry’s first completely modular fleet management solution. The company’s patented analytics, mobile touch screen GPS units and electric golf carts are sold around the world through a network of established distributors and partnerships with notable brands in fleet and equipment manufacture. VTS solutions also have applications in managing commercial, agricultural, military and government fleets. VTS is a wholly owned subsidiary of DSG Global.

Market Outlook

The global EV market was valued at $273 billion in 2017, according to Fortune Business Insights, and is projected to exceed $987 billion by 2027, with a projected CAGR of 17.4 percent. The relative high manufacturing costs of EVs compared to gasoline-powered vehicles and the resulting higher sticker price to consumers are major obstacles to near term market adoption.

The global e-bike market is estimated to grow to $70 billion by 2027 from its current valuation of $41.1 billion. An estimated 130 million e-bikes are expected to be sold globally over the next two years. The U.S. imported approximately 600,000 e-bikes in 2020, according to the Light Electric Vehicle Association, and its analysts expect that number will grow substantially in 2021.

Management Team

Robert “Bob” Silzer is the CEO of DSG Global. He is a serial entrepreneur who turns technology ideas in high growth industries into profitable businesses. With roots in the golf industry, he founded Vantage Tag Systems in 2008. Vantage Tag Systems is now a DSG subsidiary specializing in GPS-enabled fleet management.

Zahir Loaiza is the interim CFO of DSG Global. She assumed the role in March 2021, after having previously served as the company’s Corporate Controller. Her diverse international experience includes working at a publicly traded mining company, several law firms and more in the U.S., Canada and South America. Prior to pursuing a career in corporate finance, she was the owner of two retail entities.

Rick Curtis is the president and COO of Imperium Motor Company, the automotive subsidiary of DSG Global. His 40-year background in the automotive industry includes manufacturing, vehicle distribution, parts distribution, service management, dealer development and executive management of dealer groups. Prior to joining Imperium, Mr. Curtis served as president of Mullen Technologies and grew the company into a world class provider of electric vehicles, battery technology and energy storage systems.

William “Bill” Rex is president of Imperium Motor’s EV Bus and Motor Home Division. He has more than 40 years’ experience at suppliers of buses/electric buses, motor homes, trucks, specialty vehicles and batteries. He is the founder of Rexhall Industries Inc., formerly a publicly traded manufacturer of RVs and distributor of buses and coaches. He previously served as president of THOR West, a subsidiary of THOR Industries that manufactures shuttle buses, and as president of BYD Coach and Bus.

Patrick J. Parenti is the SVP Global Sales at DSG subsidiary Vantage Tag Systems. He has nearly 30 years of experience in golf and golf course management. Prior to joining DSG in 2012, Mr. Parenti served for 10 years as SVP at ProLink Systems, a leading global provider of GPS golf-course management systems.

Clint Singer is Director of Engineering at Vantage Tag Systems. He has been a senior developer in the golf industry for more than 20 years and has an extensive background in GPS systems.

Daniel Price is Technical Operations Manager of DSG Global’s European Region, UK, South Africa. In addition to his background in mechanical and electronic engineering, he is an audio engineer, specializing in automotive audio and security. He has also worked with high end electronic security companies in the UK and previously owned an electronic security and CCTV company.

Steven Mueller is Operations Manager at Vantage Tag Systems. He worked in the global pulp and paper market for nine years, facilitating the global movement of thousands of tons of timber products annually. Additionally, he has a successful decades-long track record of managing operations and consulting for a wide range of retail businesses.

DSG Global Inc. (DSGT), closed Wednesday’s trading session at $0.24195, up 5.1957%, on 1,596,317 volume.The average volume for the last 3 months is 648,223 and the stock's 52-week low/high is $0.106/$1.52.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global (OTCQB: SHRG) is positioned in a growing market where, according to a recent Direct Selling Association report, sales grew almost 14% last year in the United States. Sharing Services stands to benefit from this trend with its focus on innovating its direct-sales efforts, including the rebranding of its subsidiary operating in this space. “SHRG’s The Happy Co. launched in February 2021 and offers functional beverages, capsules, patches and creams that elevate mood, boost energy, reduce stress, enhance sleep, increase muscles, minimize fat and tighten skin,” reads a recent article about the products that are formulated to make users look, feel and perform like a younger person. “The products are nootropics, or nutraceutical formulations derived from food sources that provide health benefits above and beyond basic nutritional value.” To view the full article, visit

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

469.304.9400 x 201

Sharing Services Global Corporation (SHRG), closed Wednesday’s trading session at $0.0887, up 0.225989%, on 82,208 volume.The average volume for the last 3 months is 1.596M and the stock's 52-week low/high is $0.0773/$0.469.

Recent News

Golden Triangle Ventures Inc. (OTC: GTVH)

The QualityStocks Daily Newsletter would like to spotlight Golden Triangle Ventures Inc. (GTVH).

More than six years after hemp pilot programs were launched by the 2014 Farm Bill, the nascent sector is still plagued by patchwork state legislations and little if any federal regulation. As more farmers dip their toes into the hemp space and it becomes more lucrative, industry players and  lawmakers alike have consistently urged the U.S. Department of Agriculture (“USDA”) to craft standardized hemp rules. Now, the National Association of State Departments of Agriculture (“NASDA”) is asking the USDA to expand hemp farmers’ access to federal grants by allowing for two different classifications based on its intended use. If the federal grant program is expanded for hemp farmers, the additional sources of hemp biomass for manufacturing entities such as Golden Triangle Ventures Inc. (OTC: GTVH) could significantly expand since farmers would be able to grow the plant on larger tracts of land.

Golden Triangle Ventures Inc. (OTC: GTVH) is a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can help assist and develop into unique opportunities.

Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces.

The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent these three sectors in which the company aims to do business.

Health Division – Global Health Services

Global Health Services is a wholly owned subsidiary of Golden Triangle Ventures (operating under its Health Division). Dedicated to the promotion of well-being and natural wellness, the company currently does business in the industrial hemp/CBD industry. Additionally, the company has a vision to promote, market and generate sales for a myriad of products and services which include a full retail line of high-end, all-natural health, wellness and beauty products.

To help achieve this vision, Global Health Services is in the process of further developing an extensive online portal that will support the multiple verticals under the company and provide a one-stop-shop for all of the company’s products and services. Moreover, to support overarching business goals, senior management tirelessly works on acquiring and building an array of profitable assets and projects.

Entertainment Division – Lavish Entertainment

Lavish Entertainment (EpicRaves) is a wholly owned subsidiary of Golden Triangle Ventures under its Entertainment Division. Operating out of Las Vegas, Nevada, the company started doing business in 2017 and was established with a vision of becoming a nationally recognized concert production company. The company currently has more than 30,000 national followers and nearly 100 team members who have helped the company successfully organize some of the most exciting Electronic Dance Music concerts in Las Vegas.

Lavish Entertainment is currently doing business as EpicRaves, which will eventually become a wholly owned subsidiary of Lavish Entertainment as the company expands its business into a variety of other forms of entertainment. The company is currently building a unique virtual reality platform to help expand on its live events, and it is working to acquire a 68,000 sq. ft. event center with a vision to develop one of the most advanced event centers in the world.

Technology Division – HyFrontier Technology

HyFrontier Technologies is a wholly owned subsidiary of Golden Triangle Ventures under its Technology Division. The company owns a patent-pending process and device technology called HyGrO, which is a molecular hydrogen and oxygen delivery system for agriculture. Golden Triangle Ventures is assisting the company in commercializing the HyGrO unit for farm and home use in markets across the globe. HyFrontier Technologies has a mission to improve global crop production efficiency by producing hydrogen and oxygen directly in the water stream.

This technology can be used on any species of plant life in nearly any grow medium. Additionally, the system can be retrofitted to wellheads for large-scale agricultural projects, indoor grow operations and small farms or utilized for a multitude of residential home and garden applications. In-house testing has shown evidence that hydrogen is capable of increasing crop yields by up to 25% and, in many circumstances, a much higher amount. Larger root systems and better overall plant health were also observed by watering plants with the HyGrO unit. Universities and multiple third-party testing facilities are currently working to validate the HyGrO technology, and all preliminary results are extremely positive.

To push the development and commercialization of the technology, management is now in the process of moving the company headquarters from Colorado to Florida, which will transition its operations into a 7,800 sq. ft. state-of-the-art manufacturing facility. The company recently executed a three-year lease with an option to purchase the entire 24,000 sq. ft. building, which will help the business in achieving its ultimate goal of commercializing this technology to the world.

Food & Wine Division – Napa Wine Brands

Napa Wine Brands is a wholly owned subsidiary of Golden Triangle Ventures which is a synergistic business with a mission of providing a world-class portfolio of unique brands birthed from Napa Valley and Sonoma Valley in the heart of California’s Wine Country.

The company has a commitment to manufacture and distribute specialty wines, foods and unique items while tapping into an array of hidden markets in the food and beverage industry. With extensive resources and award-winning products, Napa Wine Brands aims to develop some of the most desirable products in today’s market. Originated by some of the most profound experts in Napa Valley, the company’s vision is to broaden the horizon of a traditional food and wine company by creating a platform different than anything seen in the Northern Hemisphere.

Napa Wine Brands has an array of fully developed products and services that provide value to the other divisions under Golden Triangle Ventures. The company is now preparing the launch of several brands, products and services that are market-ready and will immediately turn into cash-positive businesses. Golden Triangle Ventures will provide a full support system and assist management of Napa Wine Brands in growing this company into another fun, exciting and profitable division of Golden Triangle Ventures.

Recent Updates

  • On May 26, 2021, Golden Triangle announced its acquisition of The Lodge Winery & Olive Oil Co. under the company’s Napa Wine Brands subsidiary. The Lodge Winery & Olive Oil Co. is an established wine brand that produces award-winning wines, olive oils and wine vinegars. “Our marketing team is now ready to launch an in-depth program focused on driving our products into big box stores, smaller retail outlets, online platforms and many other avenues,” Steffan Dalsgaard, CEO of Golden Triangle, stated in a news release announcing the acquisition. “We are working directly with [Napa Wine Brands CEO] Arron [Johnson] and his team to grow their bulk inventory and launch all of these products for the world to enjoy.”
  • On May 20, 2021, Golden Triangle announced its entry into a letter of intent to acquire Sonder Fulfillment LLC, a leader in the industrial hemp and CBD space that is dedicated to driving forward the most powerful and efficacious cannabinoid products in the world. “Over the past two years, our operating partners have compiled a team of the best minds in the industrial hemp industry to create a totally vertical operation from seed to shelf,” Joshua Weaver, CEO of Sonder Fulfillment, stated in a news release announcing the LOI. “This acquisition by Golden Triangle Ventures will fully capitalize our operations and allow us to further expand our product lines and enter into new markets across the globe.”
  • On May 19, 2021, Golden Triangle announced the execution of a formal agreement with Robert “Bo” DuBose to purchase the remaining 49% of HyFrontier Technologies Inc., giving Golden Triangle 100% ownership of the technology company. “This acquisition has been something that Bo and I have been working towards for quite some time and we are both incredibly happy to have this executed,” Dalsgaard stated in a news release announcing the acquisition. “We knew that completing this agreement would show the world that we are both fully committed to our shareholders and the brilliant future of this revolutionary company.”
  • On May 12, 2021, Golden Triangle announced its acquisition of a top tier, professional sound system and formed a partnership with SuperKollider Sound LLC to provide a strategic benefit to the company’s entertainment division under Lavish Entertainment Inc. “We are very excited to acquire this unbelievable sound system,” Dalsgaard stated in a news release announcing the acquisition. “Hennessey Sound Design has always been one of my favorite systems on the market, and the team at SuperKollider Sound are true professionals in this space.”

Management Team

Steffan Dalsgaard is the Founder & Executive Chairman of Golden Triangle. He has a background in business development, with over a decade of experience representing and consulting with dozens of private and public companies. Mr. Dalsgaard consults with companies on all of their corporate objectives while providing a professional and corporate face to their organizations. He has built a strong reputation in the public relations industry and has a mission to work with emerging growth companies that are positioned to become significant businesses in their respective fields.

Robert DuBose is the company’s Chief Innovations Officer & Director and the CEO of HyFrontier Technologies Inc. Mr. DuBose is responsible for the success of the HyGrO product in the agricultural market. His experience in the design and production of hydrogen equipment goes back more than a decade, including PEMFC technologies since 2009 with his company, Aquafuel Inc. Mr. DuBose was raised in the farming and machine shop business, where he learned firsthand how much work and love goes into a successful crop, as well as how elements, which are out of the farmers control, can have adverse effects on finances. His belief that being able to deliver a solution to increase growth, yield, health, stamina of crops and profitability for farmers would be a win-win for all led him to create the HyGrO product.

Stuart Seim is the Chief Development Officer & Director of Golden Triangle. He began his career as an associate professor at the University of Manitoba in the field of outdoor and environmental education after receiving his master’s degree and completing advanced educational studies. Coming from a family with an extensive financial background, Mr. Seim became a stockbroker for major regional financial firm Robert W. Baird. In a short time, he became the Branch Manager for Baird in Minneapolis, Minnesota, while also serving as a Managing Director for Baird. During this time, Mr. Seim also served on the board of an industrial hearing company, which he helped to launch as a new company (The TK Group). Mr. Seim currently resides in Colorado, where he is an advisor to several organizations.

Golden Triangle Ventures Inc. (GTVH), closed Wednesday’s trading session at $0.0636, up 9.6552%, on 6,684,629 volume.The average volume for the last 3 months is 82,208 and the stock's 52-week low/high is $0.022/$0.9499.

Recent News

Simply Sonoma Inc.

The QualityStocks Daily Newsletter would like to spotlight Simply Sonoma Inc.

  • “CBD may offer an option for treating different types of chronic pain,” reports Harvard article
  • Topical CBD could help lower pain and inflammation due to arthritis, notes one study
  • According to Simply Sonoma, the inflammation market represents a $100-billion opportunity and is one of three areas the company is working in

CBD, or cannabidiol, the second most prevalent of the active ingredients of cannabis, is gaining attention as a potential effective therapy for many uses, including inflammation. A recent article from Harvard Health Publishing notes the progress being made in that area (, an area that Simply Sonoma is heavily focused on.

Simply Sonoma Inc. produces healthy CBD medicinals and beauty products for the environmentally conscious consumer. The company strives to create the best sustainably grown natural medicinal alternative products and is committed to minimizing its carbon footprint by powering operations off-the-grid using solar energy. Simply Sonoma is creating unique medicinal hemp strains that are alternatives and supplements to traditional, chemically manufactured therapies. The company believes in all-natural, organically sun-grown, plant-based medicinals, and it provides consumers with science-based education on CBD for disease and lifestyle needs.

Simply Sonoma is focused on being a leader in the industry for plant-based medicinal health and beauty products and partnering with like-minded organizations. The company strives to develop broad-spectrum CBD products for therapeutic applications from a scientific perspective. Its products come from the farm rather than from a lab, with the goal of achieving fewer side effects and more efficacy for patients. The company believes in published, science-based trials and research with regard to its CBD creations.

Simply Sonoma is a different kind of natural company. From seed to sale, it owns or contracts the organic grow, extraction and product formulation operations. The company has been developing products since 2017 based on scientific research and data and has several ready to launch. Its nationally available organic CBD products employ the company’s own proprietary formulations.

For example, the company’s nonalcoholic CBD Pinot Noir beverage uses grapes specially grown for Simply Sonoma and is infused with CBD from the company’s farm. The company expects to generate revenue through national sales of its CBD products via e-commerce, as well as through a variety of chain stores, pharmacies and small businesses throughout the U.S.


Simply Sonoma has three tiers of products:

  1. Organic CBD formulations for consumer medicinal applications.
  2. Organic whole plant extracts of CBD and cannabinoids – providing the whole plant synergistic effect and giving a dose response for a variety of diseases.
  3. Organic extracts paired with traditional over-the-counter functionality, delivering all the benefits of traditional OTC products but the bulk product is organic and plant derived for a more natural healthy approach, minimizing synthetic chemical components and adverse effects.

An example of tier three would be the company’s sleep aid. Current over-the-counter and prescription sleep aids like benzodiazepines, antihistamines and sleeping pills disrupt normal sleep brain patterns including REM, resulting in abnormal sleep. CBD and cannabinoids have efficacy as sleep aids and do not disrupt the normal sleep cycle.

Depending on the application, the company’s products can be delivered via:

  1. Teas
  2. Pills
  3. Inhalers
  4. Skin patches
  5. Gummies
  6. Tablets
  7. Sublingual sprays
  8. Tinctures
  9. Topicals
  10. Juices

Simply Sonoma has partnered with Sonoma Biologics, a premium hemp cultivator that has completed considerable research on the scientific nature of hemp and cannabis, to grow proprietary medicinal strains specifically for the company. Additionally, Simply Sonoma is working with Organic Vineyards on the company’s antioxidant, alcohol free, CBD wine product, as well as its low carb, low sugar Pinot Noir CBD sparkling product. All partner companies are environmentally conscious, solar first and organic-equivalent. Simply Sonoma’s CBD products will contain less than 0.3% of THC.

Market Outlook

Simply Sonoma competes with numerous nondescript CBD companies in the market today. The company feels its major competitive advantage is its scientific staff and product formulation expertise. Simply Sonoma products are focused on four specific health, beauty and lifestyle markets, including sleep aids, joint pain, probiotics and skin health. The Market Data Forecast valued the global sleep aid market at an estimated $175 billion in 2020. The joint pain and anti-inflammatory market is forecast to be worth approximately $41 billion in 2026 by Persistence Market Research. The market for gut health and probiotic products is expected to hit $65 billion by 2023, according to Global Market Insights. Allied Market Research valued the global beauty and skin product market at $380 billion in 2019.

Management Team

Simply Sonoma’s dynamic team has a unique combination of experience that positions them well with the company’s wellness and lifestyle products in the CBD space.

Margaret C. Caracciolo is the CEO of Simply Sonoma. She has spent most of her career in biotechnology, in the areas of clinical research and financials. She has worked for notable biotech companies including Heartport, an innovator of heart therapies. She spent time at Aviron, supporting the development of its innovative nasal flu inoculation product, and Genitope, which created personal gene therapies. She has spent the last 10 years co-managing her family’s farm and vineyard and creating wines and other products from the farm’s organic gardens.

Angela Miller is Vice President of Operations at Simply Sonoma. She has extensive experience in cross line-of-business, global project management, and analysis from inception to post-go-live. She spent more than 20 years working at Oracle Corp. and Sun Microsystems Inc., where she obtained expertise in global products, team building, troubleshooting, and customer relations. She also worked seven years with Schwinn Cycling & Fitness, doing everything in the Fitness Division from project management to marketing and public relations.

Recent News



The QualityStocks Daily Newsletter would like to spotlight reAlpha

reAlpha, a cutting-edge technology company with a plan to empower everyone to invest in the $1.2 trillion short-term rental market, announced that it is raising up to $75,000,000 pursuant to Regulation A+. According to the announcement, reAlpha’s common stock is now available for purchase at a price of $10 per share. Interested parties should visit to access the offering circular and learn how to invest.

reAlpha is the Robinhood of Airbnb investments, representing the intersection of modern technology and lasting assets. A new wave of investment opportunities in real estate has emerged, and Airbnb short-term rentals are changing hospitality and travel on a global scale. Previously, only accredited investors have had access to the best real estate deals, but reAlpha is democratizing this lucrative new model, empowering anyone to generate wealth as a reAlpha member. reAlpha uses its proprietary, disruptive technologies to level the playing field, unraveling the industry’s high barriers to entry and bringing the power of real estate investing to the “99 percent.”

The company’s unique model allows investors to benefit from both the superior returns of short-term rental income and increases in property value through renovation and appreciating markets. reAlpha likens this double investment return to seeing two desserts on a dinner menu and ordering both.

The company seeks to open up access to real estate investing by letting regular people buy fractional ownership of short-term rentals using reAlpha’s smartphone app. The reAlpha app simplifies the real estate investing process. In the app, investors can check out the company’s most current properties offered for investment. If they choose to invest, they become members of a syndicate invested in a specific short-term rental property. Syndicate members receive quarterly dividend payments from rental revenue generated by the property in which they invested. The reAlpha model merges the most historically stable asset – real estate – with technology and the sharing-economy business model of the future – Airbnb.

The company handles all property management functions and believes short-term rentals are no longer purely transactional and occupancy-driven. reAlpha reimagines the entire guest experience end-to-end to make sure the reAlphaHouse is the ultimate on-demand rental property. The company plans to implement various technologies, including smart locks, voice-activated electronics, home automation systems, and innovative furnishings, to create an unparalleled guest experience. When guests have exceptional stays, investors enjoy maximized profits.

How it Works

reAlpha has identified specific markets in which to purchase short-term rentals across the globe. The company prefers to buy 100 to 500 properties in each market. reAlpha uses artificial intelligence technology, dubbed reAlphaBRAIN, to select “unicorn properties,” the best available opportunities in the market for investment. The AI software can quickly evaluate thousands of property listings based on 25+ factors and assign each a reAlphaScore, projecting how Airbnb Viable the property is, as well as its projected value in the housing market.

For a minimum investment of $2,500, an investor can purchase equity in a specific reAlpha property, similar to how they would buy stock or shares in a company. reAlpha matches the investor with other like-minded backers to form a syndicate, so together they can cover a down payment on the selected property. Investment properties usually require a down payment of 25 percent of the purchase price, but, with reAlpha properties, the down payment is only 10 percent because of the company’s relationships with lenders, making the initial investment more affordable.

reAlpha maintains a majority stake in each investment syndicate, retaining 51 percent ownership in each purchased property and ensuring their interests are always aligned with investing members. Properties are typically refinanced after 12 to 16 months, freeing equity for reinvestment in additional properties. The company uses its AI software to predict optimum timing to sell properties in order to extract maximum value for investors. Gains are reinvested in additional properties. However, reAlpha also believes that real estate investing is more than financial returns. It includes the pride of ownership and the freedom of financial security. reAlpha members have access to their property when it is not rented out on Airbnb. The company is driven every day to create not only lucrative returns for its members but also to deliver exceptional experiences and positive impact in the communities in which reAlpha lives and operates.


Market Outlook

There are an estimated 7.4 million short-term rental properties worldwide. The total asset value of this global market is projected at $1.2 trillion. In the U.S. there are about 1.8 million short-term rental properties. These have an estimated asset value of $933 billion. Brain Chesky, the CEO of Airbnb, recently stated that there is a shortage of properties to meet demand and that the company will need “millions of more hosts.” reAlpha is projecting that the company and its investors will own 5,000 short-term rental investment properties by 2025. reAlpha forecasts annual revenue of $434 million by 2025.

Management Team

Giri Devanur is the CEO and co-founder of reAlpha. Prior to founding reAlpha, he served as president and CEO of enterprise software company Ameri100 Inc. from its founding in 2013. He scaled Ameri100 from zero to $50 million in revenue and took the company public in 2017. That same year, he was named E&Y Entrepreneur of the Year. He immigrated to the U.S. with virtually no possessions and $65 in the bank. He earned a Master’s in Technology Management from Columbia University, where he continues to mentor aspiring entrepreneurs.

Monaz Karkaria is the COO and co-founder of reAlpha. Prior to reAlpha, she founded real estate management firm Ben Zen Properties LLC. She has also worked in branch operations for Citibank. Before her involvement in Citibank, she worked at Berlitz in Sao Paulo, Brazil, as an ESL business coach and consultant for various international business clients like GE, Google, PepsiCo and others. She began her career in sales and marketing at Smith & Nephew Dubai. She is also a popular real estate coach and speaker.

Mike Logozzo is the CFO of reAlpha. Prior to joining the company, he served as Managing Director, Americas for innovation advisory firm L Marks. Before that, he was General Manager, Financial Services Operations, Americas Region for BMW Group Financial Services, where he also held Special Projects Manager and CIC Strategy Manager positions.

Christie Currie is the CMO of reAlpha. Previously, Christie launched her own business in the MedTech space, Zandaland, where she worked closely with large enterprises and health care systems. Currie’s work in the startup community led her to London-based corporate innovation firm L Marks, where she led world-leading corporations in retail, supply chain and logistics, and health care to identify strategic areas of need and successfully engage industry-disrupting startups. Currie has mentored hundreds of these startups, helping them to align their technology solutions with market needs.

Recent News


Nemaura Medical Inc. (NASDAQ: NMRD)

The QualityStocks Daily Newsletter would like to spotlight Nemaura Medical Inc. (NASDAQ: NMRD).

  • NMRD has developed a proprietary technology that replaces traditional invasive methods of diagnosis and healthcare observation procedures
  • Report notes that study participants are interested in using electronic methods to communicate more with their doctors between visits
  • Better communication between patients and their healthcare providers impacts adherence to prescribed treatment

According to a report published in Dove Medical Press, communication between patients and their physicians has a notable impact on adherence to prescribed treatment and improved health care ( As a company focused on providing digital and glucose monitoring solutions for patients dealing with diabetes, Nemaura Medical (NASDAQ: NMRD) pays special attention to essential information and research that impacts the successful implementation of its solutions.

Nemaura Medical Inc. (NASDAQ: NMRD) is a medical technology company developing affordable diagnostic and digital tools for chronic disease management. Its flagship product, sugarBEAT®, is a wearable, non-invasive and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and prediabetes manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading.

sugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with a smartphone app displaying glucose readings at five-minute intervals for periods of up to 24 hours. One of the great advantages of the product, apart from the fact that users no longer need to draw blood samples or prick their fingers, is that a person can wear the CGM patch on whatever day they choose. Existing CGM devices must be implanted under the skin. Wearable disposability is a unique feature of sugarBEAT and a world first, opening up vast potential for changing the way people manage their chronic disease conditions. sugarBEAT received CE mark clearance in May 2019, allowing it to be marketed and sold within the European Union as a Class 2b Medical Device. The company submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration in 2020 which is currently under review.

Founded in 2011, Nemaura set out to develop a single platform technology to measure blood markers at the surface of the skin. Since then, the company has evolved with the creation of wearable technologies and digital health care solutions that encourage and empower people to take charge of their own health and well-being. Nemaura’s skin surface blood monitoring technology has allowed the company to create additional products, which are in the pipeline, such as Lactate Monitoring.


Digital Solutions for Weight Loss and Potential Reversal of Type 2 Diabetes

This is a digital program that comes with more than a decade of clinical evidence demonstrating excellent efficacy. The company has combined this with its glucose-monitoring platform to bring a product to market to help people with diabetes manage their condition and potentially reverse Type 2 diabetes.

Glucose Monitoring Solutions for Diabetes Prevention and Reversal

Over 420 million people worldwide are living with diabetes, and prediabetes cases total almost three times that number. Undoubtedly, diabetes is an urgent global health crisis. Combining clinical research with patient-friendly technology, Nemaura’s sugarBEAT product delivers a non-invasive, affordable and flexible method of blood glucose tracking for improved diabetes management.

Continuous Lactate Monitoring for Athletic Performance (Non-Medical)

Lactic acid is a key performance indicator for the body and a guide to how well muscles react to long term exertion and recovery. Well-trained athletes and those who regularly engage in sports are very efficient at faster lactate ‘recycling’ for extra energy (ATP). Nemaura expects to launch its lactate sensor to the sports and personal training market in 2022.

Continuous Lactate Monitoring in Disease State (Medical)

An increase in blood lactate levels is also a marker of critical disease states. Recent publications have indicated the presence of elevated lactate levels in patients with COVID-19 infection. Nemaura has developed a lactate sensor that is being integrated into the company’s platform, which will be submitted for regulatory clearance upon completion of requisite clinical studies.

Continuous Temperature Monitoring for Viral Infection Detection and Disease Progression

A person’s body temperature says a lot about their health. Several diseases, including COVID-19, are characterized by an increase in body temperature, so temperature monitoring is a vital tool in the detection, diagnosis and prevention of the spread of disease. Nemaura is expecting to submit this adaptation of the device for regulatory clearance in 2022.

Market Opportunity

Obesity and diabetes are two of the major drivers of the current chronic disease epidemic. According to the International Diabetes Federation, there are more than 463 million people living with diabetes worldwide. In the U.S., about 28,000 people are diagnosed with diabetes every week, and more than 34 million suffer from diabetes. Another 88 million Americans have prediabetes. Other industrialized countries show similar numbers based on their populations. In the U.K., 4.8 million people have diabetes, with another diagnosed every two minutes. In Germany, 9.5 million have diabetes, with almost half estimated to be undiagnosed and so at greater risk.

On average, employers and insurers spend more than $9,000 annually on health care for an employee with diabetes, compared to $1,600 annually for a healthy employee. In the U.S. alone, more than $760 billion was spent on diabetes-related health care expenditures during 2019. Nemaura is positioned at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50-plus billion prediabetic market, and the wearable health-tech sector for weight loss and wellness applications forecast to hit $60 billion by 2023.

Management Team

Dr. Faz Chowdhury has been CEO and chairman of the board of Nemaura Medical since 2013. He has more than 20 years of experience in the pharmaceutical and medical devices industry, taking products from concept to commercial launch. He is sole inventor on more than 100 granted and pending patents and has authored textbook chapters on nano-biosciences for Wiley and Elsevier. He holds a master’s degree in microsystems and nanotechnology from Cranfield University, and a doctorate from the University of Oxford in nano-medicine and drug delivery.

Justin Mclarney is CFO at Nemaura. He most recently was the Senior Director, International Finance at Lands’ End Inc. He also worked for Office Depot as Senior Director of Finance for the largest business unit within the European group. Prior to that, he spent more than 10 years in practice, the majority of which was with Ernst & Young LLP.

Dr. Fred Schaebsdau is Vice President of Strategy & Strategic Alliances at Nemaura. He has more than 15 years of executive experience in the CGM, blood glucose monitoring and insulin delivery industries, including time with Abbott Diabetes Care, as General Manager of Dexcom Germany and at Roche Diabetes Care, where he was Senior Vice-President, Head of Global Strategy and Business Development. The firm he founded is the exclusive distributor in Europe, the Middle East and Africa of UniStrip®, the world’s first generic blood glucose test strip. He is licensed to practice medicine in the U.S. and Germany.

David Scott is Director of Commercial Development and Licensing at Nemaura. He is a trained chemist with over 35 years of experience in the pharmaceutical industry, including deal brokering, marketing, strategic planning, finance, business development and acquisitions. He has also provided licensing training for a number of multinational pharma companies and training organizations and is the author of best-selling report Scrip’s Practical Guide to Pharmaceutical Licensing.

Nemaura Medical Inc. (NASDAQ: NMRD), closed Wednesday’s trading session at $5.96, off by 0.996678%, on 25,241 volume.The average volume for the last 3 months is - and the stock's 52-week low/high is $3.3013/$17.40.

Recent News


The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, recently announced its Q2 2021 results. The company reported Q2 revenues of $7.7 million, up 557% year over year and rising by 41% quarter on quarter. The company also updated its corporate revenue, noting Q3 guidance of $8.3 million, which would represent at least a +7.7% quarter-on-quarter increase. It increased its full-year revenue target to 32 million, from $30 million previously. The company also announced it would be carrying out a $10 million stock buy-back program and one-time special dividend payout. A recent article reads, “SRAX’s corporate action announcements come amidst a period of strong growth for the company. The company recently launched, a news website designed to aggregate data surrounding the microcap equity sector. Moreover, SRAX also recently announced that it will be hosting the upcoming 2021 LD Micro Main Event, both in-person in Los Angeles as well as virtually via its Sequire Virtual Events platform.” To view the full article, visit

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.


BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.


Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Wednesday’s trading session at $5.45, off by 0.909091%, on 125,422 volume.The average volume for the last 3 months is 25,241 and the stock's 52-week low/high is $2.06/$7.29.

Recent News

Flora Growth Corp. (NASDAQ: FLGC)

The QualityStocks Daily Newsletter would like to spotlight Flora Growth Corp. (NASDAQ: FLGC).

Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has announced its entry into an agreement to begin scientific clinical trials globally. According to the update, the focus of this study will be on the use of cannabinoids in patients suffering from fibromyalgia or chronic pain, with primary research sites located in the United States and the United Kingdom. By running phase trials in parallel (in vitro, in vivo, pilot in human, safety/efficacy, etc.), Flora Pharma expects to fast track traditional FDA and NHS timelines. “A paradigm shift is upon us where health care practitioners, researchers, patients and adult-use consumers are starting to understand, accept and embrace the therapeutic potential offered by phytocannabinoid-based medicine. To view the full press release, visit

Flora Growth Corp. (NASDAQ: FLGC) is an internationally focused cannabis brand builder that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including cosmetics, hemp textiles, and food and beverage. Flora Growth operates one of the largest outdoor cultivation facilities in the world with an aim of marketing a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, the company creates premium products that help consumers restore and thrive.

Flora Growth completed the first traditional cannabis IPO on Nasdaq in May 2021. Although currently headquartered in Toronto, Ontario, with plans to relocate its head office to Miami, Florida, the company’s base of operations is in Colombia, where it has built an extensive distribution network that includes Colombia’s largest distributors.

Currently, Flora Growth is organically growing market share for its existing brand portfolio (pharmaceuticals, textiles, cosmetics, and food & beverage) while seeking revenue-generating acquisitions that offer an accretive distribution network to amplify revenue growth.

Existing Brand & Product Portfolio

Flora Growth’s portfolio spans a number of verticals – each with a thoughtful brand designed to resonate with its intended end consumer. In line with the company’s mission, each brand prioritizes natural ingredients and value-chain sustainability.

Flora Lab S.A.S

Flora Lab is the company’s GMP certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Its offerings include product lines that are private label, white-label, and custom formulas.

Through Flora Lab, Flora Growth has relationships with 1,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds multiple GMP certifications enabling international export in an effort to leverage Flora Lab’s capacity to produce a wide range of CBD-infused products.

Flora Beauty

Flora Beauty is the company’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. Its current offerings include two CBD skincare brands targeting the U.S. and Latin American markets – MIND NATURALS and AWE. These lines exemplify Flora Growth’s socially conscious approach to business.

Currently, Flora Beauty products are offered globally through e-commerce, as well as through Falabella’s 111 retail locations across Latin America. The company is in negotiations with major department stores to launch the line in the U.S. and is also exploring opportunities in the U.K. and other European markets.

KASA Wholefoods

KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from the Amazon. KASA has a $10 million+ distribution agreement with Tropi, Colombia’s largest food distributor, which has 130,000+ distribution points across the country.

Mambe, KASA’s leading brand, is already offered through over 980 distribution points across Colombia. Flora Growth expects this network to grow to over 1,200 distribution points in 2021, including one of Colombia’s largest coffee chains, Tostao Café & Pan.

Hemp Textiles & Co.

Through its Hemp Textiles division, Flora Growth intends to utilize its large land package and cultivation infrastructure to capture market share in the rapidly growing hemp industrials segment.

The company’s first brand through this division, Stardog Loungewear, offers a line of comfortable loungewear made from natural, organic materials. Stardog has been distributing globally through e-commerce and brick and mortar channels in Bogota since fall 2020, and the company intends to open U.S. brick and mortar locations in 2021.

Accretive M&A

Flora Growth is targeting transactions to complete the supply chain via key infrastructure to enhance its global distribution with the aim to compete on low-cost, high-quality inputs paired with premium brands that create business lines with robust margins.

To date, Flora has announced two major transactions.

Koch & Gsell (Acquisition)

  • Amplify CPG portfolio’s revenue growth through leading brand, Heimat, currently with TTM revenues of $7.6 million.
  • Leverage Koch &Gsell’s distribution network of 2,500+ stores to introduce Flora to the Swiss, European and Asian markets.
  • Bring patented hemp cigarette manufacturing technology into new markets utilizing Flora’s high-quality cannabis.

Hoshi International (Investment)

  • Equity Investment of €2 million into Hoshi to establish Flora as a preferred supplier to two EU processing facilities.
  • Opens gateway for Flora Growth’s cannabis through international distribution agreements in the EU and U.K.
  • Hoshi’s experienced team and increased access to the EU cannabis market to serve as a catalyst for revenue growth.


Key to Flora Growth’s expansion efforts is its cultivation strategy. The company’s Cosechemos farm, located in Bucaramanga, Colombia, is currently licensed to cultivate 247 acres of cannabis. Through three successful pilot crop plantings, the location has demonstrated a production cost of just $0.06/gram. For comparison, the average cost of North American cannabis (based on 2019 figures from Aphria, Tilray, Sundial, and Aurora) equates to roughly $1.89/gram.
Flora Growth is uniquely positioned to capitalize on Colombia’s favorable growing conditions, low-cost infrastructure, and affordable local workforce as it looks to ramp up its cultivation efforts moving forward.

Leadership Team

Bernard Wilson is the Chairman of Flora Growth. A senior financial professional, Dr. Wilson is the former Vice-Chairman of PricewaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. He has also served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce – Canada; and Member of the Canada/U.S. Trade Committee. Dr. Wilson draws on this experience to ensure Flora Growth adheres to effective corporate governance practices.

Luis Merchan is the company’s President and CEO. He is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. Mr. Merchan previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations, where he managed the enterprise’s multi-billion-dollar P&L expense line for the entire 540 store portfolio. Throughout his tenure at Macy’s, he led various sales and marketing initiatives, including the B2B corporate sales team that was responsible for $160 million in annual revenue. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia, and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard.

Juan Manuel Galan is a Strategic Advisor to the Flora Growth management team. Mr. Galan currently serves as a senior consultant to The World Bank. He is a politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galan was a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia.

Stan Bharti is a Director of Flora Growth. Mr. Bharti currently serves as Executive Chairman of Forbes & Manhattan. He has more than 30 years of professional experience in business, finance, markets, operations and more, with a focus on the resource and technology sectors. To date, Mr. Bharti has amassed over $3 billion worth of investment capital for the companies with which he has worked and their shareholders. He is a Professional Mining Engineer and holds a master’s degree in engineering from Moscow, Russia, and University of London, England.

Javier Franco is the company’s VP of Agriculture. Mr. Franco is a master horticulturist with more than 25 years of experience in the design, implementation, and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America. He completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial, and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices.

Flora Growth Corp. (FLGC), closed Wednesday’s trading session at $5.1, off by 3.7736%, on 665,181 volume.The average volume for the last 3 months is 92,027 and the stock's 52-week low/high is $2.85/$21.45.

Recent News

Vivos Therapeutics Inc. (NASDAQ: VVOS)

The QualityStocks Daily Newsletter would like to spotlight Vivos Therapeutics Inc. (NASDAQ: VVOS).

Nemours Children’s Health director of preventive cardiology Dr. Carissa Baker-Smith stated in a recent interview that disrupted and poor sleep in children could be linked to difficulty focusing in the daytime. This, she added, could negatively affect their performance in school. Sleep apnea is a sleeping disorder known to cause serious health problems. When untreated, sleep apnea causes an individual’s breathing to stop repeatedly while they’re sleeping. This, in turn, causes loud snoring and fatigue in the daytime, despite having a full night’s sleep. If sleep apnea is positively diagnosed, remedies made by companies such as Vivos Therapeutics Inc. (NASDAQ: VVOS) can be of great help in addressing this condition which has the potential to trigger several other complications.

Headquartered in Denver, Colorado, Vivos Therapeutics Inc. (NASDAQ: VVOS) is an emerging global leader in the treatment of mild-to-moderate obstructive sleep apnea (OSA), a debilitating condition affecting nearly 1 billion people worldwide. The company utilizes proprietary, ground-breaking technology, a proven go-to-market strategy, and a powerful executive team dedicated to changing the face of health care by helping people of all ages properly breathe and sleep.

At the core of Vivos’ mission to rid the world of mild-to-moderate OSA is the Vivos System®, a revolutionary clinical breakthrough in the treatment of mild-to-moderate sleep apnea often caused by craniofacial anatomy development. The Vivos System® multidisciplinary treatment protocol involves collaboration between physicians, specially-trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary health care providers.

In support of its growth strategy, Vivos has established contract manufacturing facilities in the U.S., Canada and Asia.

Market & Technology Overview

Craniofacial developmental deficiencies, such as underdeveloped upper and lower jaws, are among the leading causes of OSA. According to a 2019 analysis from researchers at the University of California, San Diego, an estimated 81 million adults in North and South America suffer from moderate to severe OSA. The United States has the highest amount of these patients, with approximately 54 million adults affected, according to the report.

Registered with the FDA as a Specification Developer, Vivos develops and markets a number of oral appliances. Its technology represents the first non-surgical, non-invasive and cost-effective treatment for the estimated hundreds of millions of people globally who suffer from mild-to-moderate OSA.

Vivos integrates its specially designed, customized appliances into a patient-specific, multi-disciplinary clinical protocol, giving trained dental and medical providers the tools and roadmap needed to address certain craniofacial conditions that studies have shown to be associated with sleep-disordered breathing—including mild-to-moderate OSA.

The system’s treatment protocol involves collaboration between physicians, specially trained dentists who have received advanced training in craniofacial sleep medicine, and additional health care providers. Vivos-trained clinicians can be found in almost every major city in the U.S. and in many countries throughout the world. The company’s oral appliances have shown to be effective in over 15,000 patients successfully treated worldwide by approximately 1,200 trained dentists.

A New Paradigm in Sleep Medicine

Vivos’ proprietary system poses the potential to be the biggest breakthrough in the treatment of mild-to-moderate OSA since CPAP.

The Vivos System has been specifically designed to promote the proper growth and development of the hard and soft tissues surrounding and comprising the oral cavity, nasal cavity, upper and lower jaws, and other tissues which together form and shape the upper airway. As these areas develop more fully using the Vivos System, a patient’s airway typically widens and expands, enabling them to breathe properly through their nose. With a more open and less obstructed airway, and easier nocturnal breathing, the symptoms of SDB tend to diminish over time, and patients often report they no longer suffer from the adverse effects of SDB or OSA.

Use of the Vivos System is variable and case dependent, but typically recommended to be worn daily for 12 to 16 hours starting in the early evening and continuing overnight. The total treatment time typically ranges from 12 to 24 months, with 18 months being the approximate mean treatment time.

Biomimetic Oral Appliance

Vivos Therapeutics believes that the Vivos System technology represents the first non-surgical, non-invasive and cost-effective treatment for people with mild-to-moderate OSA.

Combining technologies and protocols that can alter the size, shape and position of the tissues of a patient’s upper airway, the Vivos System opens airway space and can significantly reduce symptoms and conditions associated with mild-to-moderate OSA.

The Vivos System treatment is typically less than $10,000 and is often reimbursable by medical insurance as an out-of-network benefit.

A potentially serious medical problem with an alternative treatment therapy available in the dental office.

Hard and soft tissues of the craniofacial complex can be non-surgically enhanced using the proprietary Vivos® System devices and clinical protocols.


R. Kirk Huntsman – CEO, Director
With experience in strategic development, technology acquisition and product planning, key talent recruitment, and target market prioritization, Huntsman brings a broad vision paired with leadership and strategic planning skills. He has significant start-up experience in a diverse range of market sectors, including medical devices, dental management, dental practice valuations and transitions, multi-location retail, financial and capital formation, consulting, outsourced services, imports and exports (China), medical services, and software and technology.

Dr. Dave Singh – Founder, Director
A doctor three times over in dental medicine, craniofacial development, and orthodontics, Dr. Singh was educated primarily in England and has lectured in North America, Europe, Asia, and Africa. The Global Summits Institute recently named Dr. Singh as one of the Top 100 Doctors in Dentistry.

Vivos Therapeutics Inc. (NASDAQ: VVOS), closed Wednesday's trading session at $3.84, off by 3.76%, on 210,923 volume. The average volume for the last 3 months is 3,356,926 and the stock's 52-week low/high is $3.78/$3.99.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) was recently featured in a NetworkNewsAudio (“NNA”) broadcast that highlights the company’s advances in making green ammonia (“NH3”) more portable, cost-efficient, and ultimately more power generating than environmentalist darling hydrogen. Its Hydrogen-Ammonia Synthesizer eliminates the pollution factor associated with traditional ammonia production, making carbon-free NH3 easy to produce where needed as a transportation fuel. Unlike hydrogen, ammonia is easy to store and transport using existing infrastructure. It is also much less expensive to manufacture carbon-free NH3 than pure hydrogen by volume, according to FuelPositive. The broadcast notes that ammonia produced in a carbon-free manner can provide fuel for commercial and public transportation and do it in a way that promotes responsible climate policy. A recent article quotes FuelPositive CEO Ian Clifford as saying, “Many people don’t know it, but planes, trains, ships, trucks, and other vehicles can be converted to run on ammonia — just as easily as they can be converted from gasoline and diesel to run on propane.” To view the full article, visit

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Wednesday’s trading session at $0.155815, off by 1.8797%, on 262,016 volume.The average volume for the last 3 months is 262,016 and the stock's 52-week low/high is $0.03/$0.326.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading